Lenacapavir (sodium)
Lenacapavir (GS-6207) sodium is a HIV-1 capsid inhibitor. Lenacapavir sodium shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells. Lenacapavir sodium displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells (PBMCs) [1].
Product Specifications
CAS Number
2283356-12-5
Product Name Alternative
GS-6207 (sodium)
UNSPSC
12352005
Target
HIV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Purity
98.51
Smiles
FC1=CC(F)=CC(C[C@@H](C2=NC(C#CC(S(=O)(C)=O)(C)C)=CC=C2C3=CC=C(Cl)C4=C3N(CC(F)(F)F)N=C4N([Na])S(=O)(C)=O)NC(CN5C(C(F)(F)[C@@]6([H])[C@]7([H])C6)=C7C(C(F)(F)F)=N5)=O)=C1
Molecular Formula
C39H31ClF10N7NaO5S2
Molecular Weight
990.26
References & Citations
[1]Singh K, et al. GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds. Front Microbiol. 2019 Jun 20;10:1227.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY403495 100 µg
KIR2.3 (KCNJ4) (NM_152868) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC683284-500 1x 500 µL
Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/3284), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042311-100 1x 100 µL
SOX10 (Melanoma Marker) (SOX10/2311R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 